Product NDC: | 51672-2097 |
Proprietary Name: | Cetirizine Hydrochloride |
Non Proprietary Name: | Cetirizine Hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; Cetirizine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-2097 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA078072 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090722 |
Package NDC: | 51672-2097-1 |
Package Description: | 1 BOTTLE in 1 CARTON (51672-2097-1) > 100 TABLET in 1 BOTTLE |
NDC Code | 51672-2097-1 |
Proprietary Name | Cetirizine Hydrochloride |
Package Description | 1 BOTTLE in 1 CARTON (51672-2097-1) > 100 TABLET in 1 BOTTLE |
Product NDC | 51672-2097 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Cetirizine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090722 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes |